Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Mesothelin

MSLN (Mesothelin) is a cell surface glycoprotein predominantly overexpressed in mesothelial cells and various tumour cells, including ovarian and pancreatic cancers. MSLN plays a crucial role in cell-cell adhesion and signal transduction. Due to its high expression in tumour cells, MSLN has emerged as a prominent target for tumour diagnosis and therapy. High MSLN expression correlates with tumour aggressiveness, drug resistance, and poor prognosis.

Anetumab
T768571954758-84-9
Anetumab is a novel fully human anti-mesothelin IgG1 antibody that is a naked antibody to Anetumab ravtansine.Anetumab can be used to synthesize the antibody-activated molecule coupling, Anetumab ravtansine.Anetumab can be used to study the treatment of metastatic pleural mesothelioma.
  • $247
In Stock
Size
QTY
Amatuximab
T76671931402-35-6
Amatuximab (MORab-009) is a humanized chimeric IgG1/k monoclonal antibody targeting cell surface mesothelin (MSLN) with antitumor activity for the treatment of solid tumors.
  • $198
In Stock
Size
QTY
BMS-986148
T9901A-075
BMS-986148 is a CHO-expressed humanized antibody-drug coupling targeting mesothelin-expressing cells for cytotoxic load delivery.
  • $450
In Stock
Size
QTY
Anti-Human MSLN Antibody (Clone HN1)
T9901A-825
Anti-Human MSLN Antibody (Clone HN1) is a humanised monoclonal antibody targeting MSLN (Mesothelin), composed of the mesothelin-specific HN1, which blocks the interaction between MSLN and CA125 with cancer cells, and can be used for cancer research.
  • $195
In Stock
Size
QTY